$NMTC
NEUROONE MEDICAL TECHNOLOGIES Corp

2015 Q4 Form 10-Q Financial Statement

#000114420415065946 Filed on November 16, 2015

View on sec.gov

Income Statement

Concept 2015 Q4 2015 Q3 2014 Q3
Revenue $0.00 $48.00 $139.00
YoY Change -65.47% -44.84%
Cost Of Revenue
YoY Change
Gross Profit $139.00
YoY Change -44.84%
Gross Profit Margin 100.0%
Selling, General & Admin $10.00K $0.00 $10.00K
YoY Change 0.0% -100.0%
% of Gross Profit 7194.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.00K $6.080K $6.259K
YoY Change 0.0% -2.86% 25.63%
Operating Profit -$6.032K -$6.120K
YoY Change -1.44% 29.39%
Interest Expense $4.034K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$4.034K
YoY Change
Pretax Income -$10.00K -$10.07K -$6.120K
YoY Change 0.0% 64.48% 19.27%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$20.00K -$10.07K -$6.120K
YoY Change 100.0% 64.48% 19.27%
Net Earnings / Revenue -20970.83% -4402.88%
Basic Earnings Per Share
Diluted Earnings Per Share -$3.945K -$1.972K -$1.972K
COMMON SHARES
Basic Shares Outstanding 5.073M shares 5.073M shares 5.073M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $0.00 $0.00
YoY Change
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables
Total Short-Term Assets $1.838K $201.00 $599.00
YoY Change 796.59% -66.44%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.838K $201.00 $599.00
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $1.838K $201.00 $599.00
YoY Change 796.59% -66.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.86K $8.102K $10.00K
YoY Change 8.94% -18.98%
Accrued Expenses $0.00 $169.00 $0.00
YoY Change -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $10.00K $20.00K
YoY Change -50.0% -33.33%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $83.33K $64.12K $26.11K
YoY Change 134.11% 145.58% -12.96%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $83.33K $64.12K $26.11K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $83.33K $64.12K $26.11K
YoY Change 134.11% 145.58% -12.96%
SHAREHOLDERS EQUITY
Retained Earnings -$180.0K -$161.0K
YoY Change 53.64%
Common Stock $5.073K $5.073K $5.073K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$81.49K -$63.92K -$25.51K
YoY Change
Total Liabilities & Shareholders Equity $1.838K $201.00 $599.00
YoY Change 796.59% -66.44%

Cashflow Statement

Concept 2015 Q4 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income -$20.00K -$10.07K -$6.120K
YoY Change 100.0% 64.48% 19.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $10.00K -$20.00K -$20.00K
YoY Change -200.0% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.00K 20.00K 20.00K
YoY Change -200.0% 0.0%
NET CHANGE
Cash From Operating Activities 10.00K -20.00K -20.00K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities -10.00K 20.00K 20.00K
Net Change In Cash 0.000 0.000 0.000
YoY Change
FREE CASH FLOW
Cash From Operating Activities $10.00K -$20.00K -$20.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15260 USD
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
17218 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
39136 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
17218 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
-4 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
74 USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
23242 USD
osok Noncash Investing And Financing Items Forgiveness Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessNotesPayableWithAccruedInterestRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
USD
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001500198
dei Document Period End Date
DocumentPeriodEndDate
2015-09-30
dei Entity Registrant Name
EntityRegistrantName
Original Source Entertainment, Inc.
CY2015Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
9966 USD
CY2015Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
169 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3000 USD
CY2015Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
46504 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
22628 USD
CY2015Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
9349 USD
CY2014Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
USD
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
64124 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
35594 USD
CY2015Q3 us-gaap Liabilities
Liabilities
64124 USD
CY2014Q4 us-gaap Liabilities
Liabilities
35594 USD
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q3 us-gaap Cash
Cash
201 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
5073 USD
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91983 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
76723 USD
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-160979 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117185 USD
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
-63923 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-35389 USD
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
201 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
205 USD
CY2014Q4 us-gaap Cash
Cash
205 USD
CY2015Q3 us-gaap Assets Current
AssetsCurrent
201 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
205 USD
CY2015Q3 us-gaap Assets
Assets
201 USD
CY2014Q4 us-gaap Assets
Assets
205 USD
CY2015Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
8102 USD
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5073000 shares
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
45000000 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5073000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Cash
Cash
525 USD
CY2014Q3 us-gaap Cash
Cash
599 USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
USD
osok Noncash Investing And Financing Items Forgiveness Convertible Notes Payable With Accrued Interest Related Party
NoncashInvestingAndFinancingItemsForgivenessConvertibleNotesPayableWithAccruedInterestRelatedParty
6952 USD
us-gaap Net Income Loss
NetIncomeLoss
-43794 USD
us-gaap Net Income Loss
NetIncomeLoss
-26367 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
9349 USD
us-gaap Accretion Of Discount
AccretionOfDiscount
330 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-4695 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8893 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-39140 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-17144 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
23876 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2014 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
22628 USD
osok Noncash Investing And Financing Items Forgiveness Accounts Payable Related Party
NoncashInvestingAndFinancingItemsForgivenessAccountsPayableRelatedParty
952 USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Interest Paid
InterestPaid
USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
USD
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2015Q3 us-gaap Operating Expenses
OperatingExpenses
6080 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
6259 USD
us-gaap Operating Expenses
OperatingExpenses
34737 USD
CY2014Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
22628 USD
CY2014 osok Adjustments To Additional Paid In Capital Gain On Forgiveness Of Related Party Debt
AdjustmentsToAdditionalPaidInCapitalGainOnForgivenessOfRelatedPartyDebt
952 USD
CY2015Q3 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
46504 USD
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
USD
CY2015Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
us-gaap Advertising Expense
AdvertisingExpense
USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34737 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26644 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-34276 USD
us-gaap Use Of Estimates
UseOfEstimates
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0;"><font style="text-decoration: underline;">Use of Estimates</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> </div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;"><font style="text-decoration: underline;">Products and services, geographic areas and major customers</font></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">The Company derives revenue from the licensing of songs to the television and music industry. All fee revenues each year were domestic and to external customers.</p> </div>
CY2014Q3 us-gaap Advertising Expense
AdvertisingExpense
USD
CY2015Q3 us-gaap Advertising Expense
AdvertisingExpense
USD
us-gaap Advertising Expense
AdvertisingExpense
USD
CY2014Q3 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
USD
us-gaap Sales Revenue Net
SalesRevenueNet
461 USD
us-gaap Sales Revenue Net
SalesRevenueNet
607 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-26037 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-43794 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-26367 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
us-gaap Operating Expenses
OperatingExpenses
26644 USD
CY2015Q3 us-gaap Interest Expense
InterestExpense
4034 USD
CY2014Q3 us-gaap Interest Expense
InterestExpense
USD
us-gaap Interest Expense
InterestExpense
9518 USD
us-gaap Interest Expense
InterestExpense
330 USD
CY2015Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4034 USD
CY2014Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9518 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-330 USD
CY2015Q3 us-gaap Sales Revenue Net
SalesRevenueNet
48 USD
CY2014Q3 us-gaap Sales Revenue Net
SalesRevenueNet
139 USD
CY2015Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6080 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6259 USD
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6032 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-6120 USD
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-10066 USD
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-6120 USD
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-10066 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-6120 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
0.00
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5073000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01

Files In Submission

Name View Source Status
0001144204-15-065946-index-headers.html Edgar Link pending
0001144204-15-065946-index.html Edgar Link pending
0001144204-15-065946.txt Edgar Link pending
0001144204-15-065946-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
osok-20150930.xml Edgar Link completed
osok-20150930.xsd Edgar Link pending
osok-20150930_cal.xml Edgar Link unprocessable
osok-20150930_def.xml Edgar Link unprocessable
osok-20150930_lab.xml Edgar Link unprocessable
osok-20150930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v424321_10q.htm Edgar Link pending
v424321_ex31.htm Edgar Link pending
v424321_ex32.htm Edgar Link pending